Tradestie Institutional Equity Comparison Engine
ENOV vs RBOT.WS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENOV Overall Edge
ENOV Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enovis Corporation (ENOV) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ENOV trades at 7.3x Forward P/E with 4.0% operating margin (+1.8% YoY revenue) versus RBOT.WS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ENOV sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro) against RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENOV
ENOV 7.3x vs RBOT.WS N/M Fwd P/E
Growth & Margin Winner
ENOV
Op Margin 4.0% vs N/A ยท YoY +1.8% vs N/A
Momentum & Technical Winner
ENOV
1Y -6.3% vs -67.2% ยท 52W Pos 59% vs 0%
Options & Structure Winner
ENOV
UNCLASSIFIED (43rd %ile IV) vs UNCLASSIFIED (N/A IV)
ENOV
NYSE
Enovis Corporation
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$25.47
-2.9% 1D
Market Cap
$1.5B
1M Return
+17.97%
1Y Return
-6.26%
Forward P/E
7.3x
Unified AI Score
30.0 / 100
SELL
Tech 15.0
Fund 28.0
Flow 50.0
Mom 21.3
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ENOV -6.26%
RBOT.WS -67.2%
Spread: +65.93 pp (ENOV Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ENOV TTM Op. Margin: 4.0%
RBOT.WS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ENOV vs RBOT.WS. Trailing 12-month operating profitability (ENOV 4.0% vs RBOT.WS N/A) and valuation multiples (ENOV 7.3x vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ENOV | RBOT.WS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | N/A | Larger Scale | ENOV |
| Trailing P/E Ratio Valuation | 7.5x | N/M | Lower Multiple | ENOV |
| Forward P/E Ratio Valuation | 7.3x | N/M | Lower Multiple | ENOV |
| Revenue Growth (YoY) Growth | +1.8% | N/A | Higher Growth | ENOV |
| Operating Margin (TTM) Profitability | 4.0% | N/A | Higher Margin | ENOV |
| Net Profit Margin Profitability | -22.9% | N/A | Higher Margin | ENOV |
| Return on Equity (ROE) Capital Efficiency | -29.9% | N/A | Higher ROE | ENOV |
| 52-Week Range Position Momentum | 59% ($17โ$32) | 0% ($0โ$0) | Stronger Trend | ENOV |
| Beta / 30D Volatility Risk Regime | 0.75ฮฒ ยท 101% Vol | N/A | Lower Realized Risk | ENOV |
| Unified Institutional Score Composite Signal | 30.0 / 100 (SELL) | 50.1 / 100 (HOLD) | Higher Composite | RBOT.WS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ENOV vs RBOT.WS Buy Guide
ENOV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ENOV nor RBOT.WS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.